FI66751C - Foerfarande foer framstaellning av ett stabilt insulinpreparatmed laongtidsverkan - Google Patents
Foerfarande foer framstaellning av ett stabilt insulinpreparatmed laongtidsverkan Download PDFInfo
- Publication number
- FI66751C FI66751C FI760058A FI760058A FI66751C FI 66751 C FI66751 C FI 66751C FI 760058 A FI760058 A FI 760058A FI 760058 A FI760058 A FI 760058A FI 66751 C FI66751 C FI 66751C
- Authority
- FI
- Finland
- Prior art keywords
- insulin
- reaction
- solution
- urea
- protamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C07K14/625—Extraction from natural sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK8375 | 1975-01-15 | ||
| DK8375AA DK140801B (da) | 1975-01-15 | 1975-01-15 | Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI760058A7 FI760058A7 (cs) | 1976-07-16 |
| FI66751B FI66751B (fi) | 1984-08-31 |
| FI66751C true FI66751C (fi) | 1984-12-10 |
Family
ID=8089535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI760058A FI66751C (fi) | 1975-01-15 | 1976-01-12 | Foerfarande foer framstaellning av ett stabilt insulinpreparatmed laongtidsverkan |
Country Status (36)
| Country | Link |
|---|---|
| JP (1) | JPS5946939B2 (cs) |
| AR (1) | AR213088A1 (cs) |
| AT (1) | AT362492B (cs) |
| BE (1) | BE837600A (cs) |
| BR (1) | BR7600206A (cs) |
| CA (1) | CA1094549A (cs) |
| CH (1) | CH631625A5 (cs) |
| CS (1) | CS208147B2 (cs) |
| DD (1) | DD124379A5 (cs) |
| DE (1) | DE2600971C2 (cs) |
| DK (1) | DK140801B (cs) |
| EG (1) | EG11988A (cs) |
| ES (1) | ES444558A1 (cs) |
| FI (1) | FI66751C (cs) |
| FR (1) | FR2297634A1 (cs) |
| GB (1) | GB1524431A (cs) |
| GR (1) | GR58608B (cs) |
| HU (1) | HU175142B (cs) |
| IE (1) | IE42395B1 (cs) |
| IL (1) | IL48845A (cs) |
| IN (1) | IN143279B (cs) |
| IT (1) | IT1054211B (cs) |
| KE (1) | KE2919A (cs) |
| LU (1) | LU74175A1 (cs) |
| MX (1) | MX4052E (cs) |
| MY (1) | MY7900169A (cs) |
| NL (1) | NL166464C (cs) |
| NO (1) | NO146698C (cs) |
| NZ (1) | NZ179733A (cs) |
| OA (1) | OA05209A (cs) |
| PL (1) | PL99927B1 (cs) |
| PT (1) | PT64696B (cs) |
| RO (1) | RO71576A (cs) |
| SE (1) | SE437219B (cs) |
| YU (1) | YU8376A (cs) |
| ZA (1) | ZA7658B (cs) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK374579A (da) * | 1979-09-07 | 1981-03-08 | Nordisk Insulinlab | Fremgangsmaade til fremstilling af et injucerbart insulinpraeparat |
| US4459226A (en) * | 1982-02-26 | 1984-07-10 | Eli Lilly And Company | Process for recovering insulin |
| US4801575A (en) * | 1986-07-30 | 1989-01-31 | The Regents Of The University Of California | Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| US4878892A (en) * | 1987-02-10 | 1989-11-07 | Drug Delivery Systems Inc. | Electrolytic transdermal delivery of polypeptides |
| AU609769B2 (en) * | 1987-02-10 | 1991-05-09 | Drug Delivery Systems Inc. | Electrolytic transdermal delivery of proteins |
| US5629020A (en) * | 1994-04-22 | 1997-05-13 | Emisphere Technologies, Inc. | Modified amino acids for drug delivery |
| US5447728A (en) | 1992-06-15 | 1995-09-05 | Emisphere Technologies, Inc. | Desferrioxamine oral delivery system |
| US6221367B1 (en) | 1992-06-15 | 2001-04-24 | Emisphere Technologies, Inc. | Active agent transport systems |
| US5714167A (en) | 1992-06-15 | 1998-02-03 | Emisphere Technologies, Inc. | Active agent transport systems |
| US5643957A (en) | 1993-04-22 | 1997-07-01 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US5750147A (en) | 1995-06-07 | 1998-05-12 | Emisphere Technologies, Inc. | Method of solubilizing and encapsulating itraconazole |
| US6051258A (en) | 1995-06-07 | 2000-04-18 | Emisphere Technologies, Inc. | Proteinoid emulsions and methods for preparation and use thereof |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| EP2662472B1 (de) | 2009-03-31 | 2019-02-27 | Boehringer Ingelheim International Gmbh | Verfahren zur Beschichtung einer Oberfläche eines Bauteils |
| US9265910B2 (en) | 2009-05-18 | 2016-02-23 | Boehringer Ingelheim International Gmbh | Adapter, inhalation device, and nebulizer |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| PE20130036A1 (es) | 2009-11-25 | 2013-02-03 | Boehringer Ingelheim Int | Nebulizador |
| WO2011064163A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2011160932A1 (en) | 2010-06-24 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2012130757A1 (de) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| WO2015018904A1 (en) | 2013-08-09 | 2015-02-12 | Boehringer Ingelheim International Gmbh | Nebulizer |
| ES2836977T3 (es) | 2013-08-09 | 2021-06-28 | Boehringer Ingelheim Int | Nebulizador |
| WO2015169430A1 (en) | 2014-05-07 | 2015-11-12 | Boehringer Ingelheim International Gmbh | Nebulizer |
| BR112016023983B1 (pt) | 2014-05-07 | 2022-10-18 | Boehringer Ingelheim International Gmbh | Contentor para um nebulizador, nebulizador para um fluido e método para conectar um contentor a um dispositivo indicador |
| EA032599B1 (ru) | 2014-05-07 | 2019-06-28 | Бёрингер Ингельхайм Интернациональ Гмбх | Небулайзер, индикаторное устройство и контейнер |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1285023A (en) * | 1968-08-09 | 1972-08-09 | Novo Terapeutisk Labor As | Improvements in or relating to injectable insulin preparations |
| US3758683A (en) * | 1971-04-30 | 1973-09-11 | R Jackson | Insulin product |
-
1975
- 1975-01-15 DK DK8375AA patent/DK140801B/da not_active IP Right Cessation
-
1976
- 1976-01-06 ZA ZA00760058A patent/ZA7658B/xx unknown
- 1976-01-07 GR GR49734A patent/GR58608B/el unknown
- 1976-01-07 IN IN41/CAL/76A patent/IN143279B/en unknown
- 1976-01-12 NZ NZ179733A patent/NZ179733A/xx unknown
- 1976-01-12 CA CA243,587A patent/CA1094549A/en not_active Expired
- 1976-01-12 FI FI760058A patent/FI66751C/fi not_active IP Right Cessation
- 1976-01-13 LU LU74175A patent/LU74175A1/xx unknown
- 1976-01-13 SE SE7600284A patent/SE437219B/xx not_active IP Right Cessation
- 1976-01-13 DE DE2600971A patent/DE2600971C2/de not_active Expired
- 1976-01-13 IT IT19221/76A patent/IT1054211B/it active
- 1976-01-13 IE IE62/76A patent/IE42395B1/en unknown
- 1976-01-14 DD DD190805A patent/DD124379A5/xx unknown
- 1976-01-14 NL NL7600338.A patent/NL166464C/xx not_active IP Right Cessation
- 1976-01-14 AT AT21376A patent/AT362492B/de not_active IP Right Cessation
- 1976-01-14 FR FR7600854A patent/FR2297634A1/fr active Granted
- 1976-01-14 BR BR7600206A patent/BR7600206A/pt unknown
- 1976-01-14 OA OA55703A patent/OA05209A/xx unknown
- 1976-01-14 YU YU00083/76A patent/YU8376A/xx unknown
- 1976-01-14 RO RO7684491A patent/RO71576A/ro unknown
- 1976-01-14 GB GB1309/76A patent/GB1524431A/en not_active Expired
- 1976-01-14 NO NO760118A patent/NO146698C/no unknown
- 1976-01-14 MX MX764822U patent/MX4052E/es unknown
- 1976-01-14 PL PL1976186526A patent/PL99927B1/pl unknown
- 1976-01-14 PT PT64696A patent/PT64696B/pt unknown
- 1976-01-15 BE BE163542A patent/BE837600A/xx not_active IP Right Cessation
- 1976-01-15 CS CS76270A patent/CS208147B2/cs unknown
- 1976-01-15 ES ES444558A patent/ES444558A1/es not_active Expired
- 1976-01-15 CH CH47076A patent/CH631625A5/de not_active IP Right Cessation
- 1976-01-15 IL IL48845A patent/IL48845A/xx unknown
- 1976-01-15 HU HU76NO198A patent/HU175142B/hu unknown
- 1976-01-16 JP JP51003293A patent/JPS5946939B2/ja not_active Expired
- 1976-01-17 EG EG16/76A patent/EG11988A/xx active
-
1978
- 1978-01-14 AR AR261924A patent/AR213088A1/es active
-
1979
- 1979-02-07 KE KE2919A patent/KE2919A/xx unknown
- 1979-12-30 MY MY169/79A patent/MY7900169A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI66751C (fi) | Foerfarande foer framstaellning av ett stabilt insulinpreparatmed laongtidsverkan | |
| US4183849A (en) | Therapeutic insulin preparation and a process for the production of a stable insulin preparation with protracted effect | |
| Brange | Galenics of insulin: the physico-chemical and pharmaceutical aspects of insulin and insulin preparations | |
| Bromer et al. | Preparation and properties of fluoresceinthiocarbamyl insulins | |
| AU612141B2 (en) | Novel insulin derivatives | |
| US5631347A (en) | Reducing gelation of a fatty acid-acylated protein | |
| Erlanson et al. | Purification and characterization of two proteins with co-lipase activity from porcine pancreas | |
| CA1172978A (en) | .alpha.-AMYLASE INACTIVATOR, A PROCESS FOR ITS PREPARATION, AN AGENT BASED ON THIS INACTIVATOR AND ITS USE | |
| FI77876B (fi) | Foerfarande foer framstaellning av humaninsulin eller en treoninb30-ester av humaninsulin eller ett salt eller komplex daerav. | |
| US3907676A (en) | Process for purifying insulin | |
| DK158677B (da) | Insulinderivater og anvendelsen deraf, injicerbar oploesning indeholdende insulinderivaterne samt fremgangsmaade til fremstilling af oploesningen. | |
| KR20020073184A (ko) | 글루카곤 유사 펩티드 1 화합물을 용해시키는 방법 | |
| IE50892B1 (en) | Process for preparing insulin esters | |
| Svendsen et al. | Isolation and characterization of the folate-binding protein from cow's milk | |
| Edmundson et al. | Isolation and characterization of concanavalin A polypeptide chains | |
| EP0032655B2 (en) | A process in purification and concentration of the factor viii-complex | |
| Hjorth et al. | Purification and identification of high molecular weight products formed during storage of neutral formulation of human insulin. | |
| Free et al. | Separation and properties of multiple components of bovine growth hormone | |
| CA1113412A (en) | Proteinic active substances | |
| JP3470135B2 (ja) | 成長ホルモンの結晶体を製造する方法およびそれにより得られる結晶体 | |
| JP2566919B2 (ja) | α−インタ−フエロンの製造方法 | |
| CA1243972A (en) | Anti-diabetic compounds | |
| EP0146842B1 (en) | Novel calcitonin and collection thereof | |
| JPWO1992014832A1 (ja) | ヒトｂｃｄｆの精製法 | |
| Tamura-Takahashi et al. | Purification and properties of four biologically active components of whale luteinizing hormone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: NORDISK INSULINLABORATORIUM |